Dell leveraging cloud computing to transform future of healthcare

View all blog posts under Articles

Computer manufacturing giant Dell is banking on cloud computing and leveraging large volumes of data to personalize healthcare, reports Information Week.

The integration of medical informatics systems, individualized genomic data and wider healthcare IT infrastructure are central to Dell’s plans to revolutionize how diseases such as cancer are treated.

In November of last year, Dell announced it would invest $4 million in cloud storage facilities and healthcare IT services to improve the quality of care in pediatric oncological treatment. Experts at the company predict that the integration of clinical informatics technology and individualized patient health information is the future of modern medicine.

“You can’t do personalized medicine without [medical informatics systems] and genomic sequencing,” Jamie Coffin, vice president and general manager of Dell Healthcare and Life Sciences, told the news source. “This [will become] the new model for genomic medicine. This is the first time we’re seeing convergence of information technology and [biotechnology].”

Coffin says that the sequencing of patient DNA structures and the availability of individual genetic data are crucial in the fight against cancer and other complex illnesses. Dell has invited a number of healthcare providers to participate in a research project conducted by the Neuroblastoma and Medulloblastoma Translational Research Consortium and the Van Andel Research Institute in Grand Rapids, Michigan. Around 15 patients will be studied during the initial round of tests, and 13 cancer treatment facilities have signed up to participate in the study.

Similar projects are in development elsewhere in the country. According to, the U.S. Department of Veteran Administration is currently developing its Veterans Health Information Systems and Technology Architecture medical informatics system to include patient genomic data to identify and successfully treat specific genetic variations of cancer cells.